^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SHR7280

    i
    Other names: SHR7280, SHR 7280, SHR-7280
    Associations

    News

    Trials
    Company:
    Jiangsu Hengrui Pharma
    Drug class:
    GnRH antagonist
    Related drugs:
    Associations

    News

    Trials
    4ms
    To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects (clinicaltrials.gov)
    P3, N=317, Active, not recruiting, Jiangsu HengRui Medicine Co., Ltd. | Recruiting --> Active, not recruiting
    Enrollment closed • Head-to-Head
    |
    SHR7280
    5ms
    A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers (clinicaltrials.gov)
    P1, N=6, Completed, Jiangsu HengRui Medicine Co., Ltd. | Recruiting --> Completed
    Trial completion
    |
    SHR7280
    5ms
    The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis. (clinicaltrials.gov)
    P1/2, N=179, Completed, Jiangsu HengRui Medicine Co., Ltd. | Recruiting --> Completed | Trial completion date: Jan 2024 --> May 2024 | Trial primary completion date: Jan 2024 --> May 2024
    Trial completion • Trial completion date • Trial primary completion date
    |
    SHR7280
    6ms
    A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers (clinicaltrials.gov)
    P1, N=8, Recruiting, Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open
    |
    SHR7280
    7ms
    A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers (clinicaltrials.gov)
    P1, N=8, Not yet recruiting, Jiangsu HengRui Medicine Co., Ltd.
    New P1 trial
    |
    SHR7280
    10ms
    Identify Effective Doses of SHR7280 Tablets in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART) (clinicaltrials.gov)
    P2, N=85, Completed, Jiangsu HengRui Medicine Co., Ltd. | Active, not recruiting --> Completed | Trial completion date: Mar 2023 --> Aug 2023 | Trial primary completion date: Dec 2022 --> Aug 2023
    Trial completion • Trial completion date • Trial primary completion date
    |
    SHR7280
    1year
    A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets (clinicaltrials.gov)
    P1, N=16, Completed, Jiangsu HengRui Medicine Co., Ltd. | Active, not recruiting --> Completed
    Trial completion
    |
    SHR7280
    1year
    To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects (clinicaltrials.gov)
    P3, N=316, Recruiting, Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open • Head-to-Head
    |
    SHR7280
    over1year
    A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets (clinicaltrials.gov)
    P1, N=16, Active, not recruiting, Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting --> Active, not recruiting
    Enrollment closed
    |
    SHR7280
    over1year
    A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets (clinicaltrials.gov)
    P1, N=16, Not yet recruiting, Jiangsu HengRui Medicine Co., Ltd.
    New P1 trial
    |
    SHR7280